[1]Naghavi M,Libby P,Falk E,et al.From vulnerable plaque to vulnerable patient:a call for new definitions and risk assessment strategies[J].Cieculation,2003,108(14):16641672.
[2]Barth JD.An update on carotid ultrasound measurement of intimamedia thickness[J].Am J Cardiol,2002,89(suppl):32.
[3]Crouse JR,Harpold GH,Kahl FR,et al.Evaluation of a scoring system for extracranial carotid atherosclerosis extent with Bmode ultrasound[J].Stroke,1986,17(2):270.
[4]邬松林,周永明,李建军,等.颈动脉粥样硬化与冠状动脉粥样硬化的关系[J].中华老年心脑血管病杂志,2006,4(3):158.
[5]Sonia SA,Salin Y,Vladmir V,et al.Differences in risk factors,atherosclerosis,and cardiovascular disease between ethenic groups in Canada:The Study of Health Aassessment and Risk in Ethenicgroups(SHARE)[J].Lancet,2006,376(9286):279284.
[6]杨水祥,胡大一.动脉粥样硬化与血管疾病危险因子重要概念回顾[J].中国心血管病研究,2004,2(2):317318.
[7]薛莉,欧阳迎春,李刚,等.氨氯地平联合阿托伐他汀钙对高血压颈动脉内膜中层厚度的影响[J].中华老年心脑血管病杂志,2008,10(9):671673.
[8]范卫清,赵云宏,熊维迪.高血压病患者颈动脉粥样硬化与心血管危险因素的相关性研究[J].中国老年保健医学杂志,2009,7(4):57.
[9]Libby P,Ridke PM,Maseri A.Inflammation in atherosclerosis[J].Circulation ,2005,108(9):11351143.
[10]Zhou ZG,Jiang Y.Effects of main inflammatory cell factors in the atherosclerosis[J].Guoji Jianyan Yixue Zazhi,2006,27(10):919923.
[11]Roivainen M,Kiik M,Kajander MV,et al.Inflammation,and the risk of coronary heart disease[J].Circulation,2005,106(4):346349.
[12]Jialal I,Devaraj S.Inflammation and atherosclerosis:the value of the highsensitivity Creactive protein assay as ariskmarker[J].Am J Clin Pathol,2001,116(Suppl):S108115.
[13]李艳玲,黄荣清,崔玉芳,等.水蛭研究概况及展望[J].科学技术与工程,2004,4(3):239242.
[14]袁继伟,焦跃军,李晶尧.中药水蛭的药理药效研究[J].中国医疗前沿,2009,4(18):18.
[15]黄伟,张碧华.脉血康胶囊的应用研究[J].首都医药,2011,17(20):3032.